Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro.

Camilla Hollander1, Max Nyström, Sabina Janciauskiene

  • 1Department of Medicine, University of Lund, SE-205 02 Malmö, Sweden. sabina.janciauskiene@medforsk.mas.lu.se

Cancer Cell International
|September 4, 2003
PubMed
Summary

Mast cells reduce secretory leukocyte protease inhibitor (SLPI) levels in airway cells but increase its mRNA. This suggests mast cell and epithelial cell interaction is crucial for inflammatory responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Inhaled Corticosteroids and Long-Acting β2-Agonists on Efferocytosis and Inflammatory Cell Survival: An In Vitro Study Relevant to COPD and Lung Cancer.

International journal of molecular sciences·2026
Same author

C-terminal α<sub>1</sub>-antitrypsin peptides as pre-transplant biomarkers for chronic lung allograft dysfunction risk stratification.

ERJ open research·2026
Same author

Alpha-1 antitrypsin-glucocorticoid receptor axis: a new pathway in immune modulation.

Molecular medicine (Cambridge, Mass.)·2026
Same author

Gender, Medical Error, and the Culture of Scrutiny in Respiratory Medicine.

Respiration; international review of thoracic diseases·2026
Same author

Clinical implications of a novel SERPINA1 variant c.236 T > A: Challenges in characterizing new rare alpha-1 antitrypsin mutations.

Molecular genetics and metabolism reports·2026
Same author

Exploring the effects of tinzaparin and cisplatin on lung cancer cells in vitro.

Cancer cell international·2026

Area of Science:

  • Immunology
  • Cell Biology
  • Respiratory Medicine

Background:

  • Mast cells accumulate at inflammation sites, releasing mediators like proteases.
  • Secretory leukocyte protease inhibitor (SLPI) regulates protease activity in respiratory mucus.

Purpose of the Study:

  • To investigate the effect of human mast cells (HMC-1) on SLPI expression and levels in co-culture with A549 cells.
  • To explore the interaction between mast cells and SLPI-producing airway epithelial cells in vitro.

Main Methods:

  • Co-culture of HMC-1 (mast cell model) and A549 (SLPI-producing alveolar cell line) for 96 hours.
  • Measurement of SLPI levels and mRNA expression.
  • Immunohistochemical analysis for mast cell transmigration.

Related Experiment Videos

Main Results:

  • Co-culture significantly reduced SLPI protein levels (2.35-fold) in A549 cells compared to controls.
  • SLPI mRNA expression in A549 cells increased (1.58-fold) under co-culture conditions.
  • Mast cell transmigration into A549 cell layers was observed at 72 and 96 hours.

Conclusions:

  • Mast cell interaction with SLPI-producing cells may facilitate mast cell migration.
  • Regulation of SLPI by mast cells likely requires direct cell-cell contact.
  • A local relationship between mast cells and airway epithelial cells is important in inflammation.